Leprosy may present kidney and endothelial abnormalities, being a risk factor for
complications. However, the involvement of renal and vascular endothelia has
been poorly investigated. We aimed to investigate if the levels of systemic
endothelial biomarkers are associated with kidney abnormalities and the clinical
forms of leprosy. This is a cross-sectional study with leprosy patients enrolled
in January 2017 to December 2018, before the initiation of the multidrug
therapy. Leprosy-associated clinical and epidemiological data were collected.
Two groups were investigated: Paucibacillary (PB) and Multibacillary (MB)
infections, for the comparisons. Serum and urine samples were obtained for
laboratory analysis. In serum samples, were evaluated the endothelial biomarkers
VCAM-1 and ICAM-1. In total, 101 leprosy patients were included, the mean age
was 48±١٥ years and 71 (70%) were male. The multibacillary form occurred in 81
cases (80%), among which 22 had the Virchowian form. Serum creatinine was more
elevated in the MB group than in PB patients. In addition, VCAM-1 was elevated
in the MB group and was correlated with the bacteriological index (rho = 0.372,
p <0.01), the duration of disease symptoms (rho = 0.234, p = 0.04), and the
number of skin lesions (rho = 0.468, p <0.001). Moreover, in MB patients who
presented albuminuria >15 mg/g of creatinine, VCAM-1 showed a significant
correlation with increased albuminuria and improved the correlation with the
number of skin lesions (rho= 0.563, p=0.010). In conclusion, higher systemic
VCAM-1 levels were associated with the multibacillary clinical form of leprosy
and with increased albuminuria. Prospective studies are necessary to establish a
cause-effect and evaluate the preventive role of these biomarkers to improve the
clinical care.